Severity
Moderate
FDA Drug recall · Reported January 1, 2025
Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
The recall
Curium US, LLC issued this moderate-severity FDA Drug recall — Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product.
Sourced from official FDA Drug enforcement records. Verify recall #D-0164-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0164-2025) was formally reported on January 1, 2025, with the manufacturer initiating the action on November 26, 2024. It is classified under Moderate severity (Class II), with a current status of Terminated. Curium US, LLC is listed as the recalling firm, operating out of Maryland Heights, MO. Federal records indicate 5,160 vials (172 kits 30 vials/kit) units are affected, placing this recall in the million-unit bracket that typically triggers nationwide consumer alerts and retailer sweeps.
The documented reason for this recall is: Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product Distribution data in the federal record shows the product reached: Nationwide USA and Canada.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC and NHTSA going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 5 were also issued by FDA Drug. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 1 year old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.
Of 83,949 recalls in the database, 21,198 are high severity, 58,883 moderate, and 3,868 low. This recall is classified moderate severity.
Severity
Moderate
Units Affected
5,160 vials (172 kits 30 vials/kit)
Related Recalls
6
5 from same agency
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40
Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0164-2025 |
| Date reported | January 1, 2025 |
| Date initiated | November 26, 2024 |
| Recalling firm | Curium US, LLC |
| Units affected | 5,160 vials (172 kits 30 vials/kit) |
| Distribution | Nationwide USA and Canada. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
Keep tracking product safety across the federal recall archive.
Recall Checker
Search the full archive by product name, brand, or recall number across every agency.
Check a product →
FDA Drug recalls
Every recall issued by FDA Drug, newest first.
Browse the feed →
RecallRadar
Live feed of the latest recalls across the FDA, CPSC and NHTSA — filter by agency and severity.
View the live feed →
Rankings
The largest recalls by units affected and the most-recalled product categories.
See the rankings →
Browse by category
Find recalls by product type to spot recurring defect patterns.
All categories →
What to do next
A step-by-step guide to refunds, repairs, and returns after a recall.
Read the guide →
Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.
Zydus Pharmaceuticals (USA) Inc · 2026-03-18
· 2026-03-12
Cipla USA, Inc. · 2026-03-11
ACME UNITED CORPORATION · 2026-03-11
ACME UNITED CORPORATION · 2026-03-11
Compare this recall with Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, … →
Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Drug, reported January 1, 2025.
Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.
Read our methodology — how this data is sourced, computed, and verified.
Source: Federal recall agencies (FDA, CPSC, NHTSA) Aggregated federal recall feeds Recall data normalized across FDA, CPSC and NHTSA feeds; severity classifications follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type).